Login / Signup

Plasma-derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency.

Miguel A EscobarKaan Kavakli
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Together, these studies support the use of pdFX for on-demand treatment of bleeding, routine prophylaxis, and perioperative management of bleeding in patients with HFXD.
Keyphrases
  • endothelial cells
  • atrial fibrillation
  • replacement therapy
  • acute kidney injury